Filter Papers to Collect Blood Samples from Dogs: An Easier Way to Monitor the Mass Vaccination Campaigns against Rabies?
ELISA
FAVN test
dogs
filter paper
mass vaccination
rabies virus
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
29 03 2022
29 03 2022
Historique:
received:
28
01
2022
revised:
21
03
2022
accepted:
23
03
2022
entrez:
23
4
2022
pubmed:
24
4
2022
medline:
27
4
2022
Statut:
epublish
Résumé
Rabies is a deadly viral disease present mainly in low-income countries of Africa and Asia. Dogs are the main reservoir and the source of human deaths. Mass vaccination campaigns of dogs are pivotal to achieve rabies elimination. The monitoring of the immune response of the dog population is necessary to evaluate the effectiveness of these campaigns, taking into account field conditions. This study explores the feasibility and the performance of a new tool using filter papers (FPs) to collect blood samples associated with an Enzyme-Linked ImmunoSorbent Assay (ELISA) titration of rabies antibodies in dogs. A total of 216 eluates from FP samples were collected from 111 dogs kept in experimental facilities in France and 29 dogs from the field in Tunisia. Sera were also analyzed using both the Fluorescence Antibody Virus Neutralization test (FAVNt) and ELISA. A high specificity (98.0%) was obtained by testing FP blood eluates from 51 unvaccinated dogs, with the results compared with those of FAVNt and ELISA on serum samples. The coefficients of concordance between FP eluates and tested sera were 88.9% for FAVNt and 88.0% for ELISA. Blood filter papers coupled with the titration of rabies antibodies by ELISA provide a reliable, simple, and effective solution to overcome the issues of the logistics and transport of samples, especially in low-income countries.
Identifiants
pubmed: 35458439
pii: v14040711
doi: 10.3390/v14040711
pmc: PMC9029112
pii:
doi:
Substances chimiques
Antibodies, Viral
0
Rabies Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Wkly Epidemiol Rec. 2016 Jan 15;91(2):13-20
pubmed: 26775296
Vaccine. 1996 Feb;14(3):185-6
pubmed: 8920697
J Virol Methods. 2012 Jan;179(1):166-75
pubmed: 22080853
Med Sci (Paris). 2013 Jan;29(1):47-55
pubmed: 23351694
Am J Trop Med Hyg. 2017 Oct;97(4_Suppl):76-83
pubmed: 29064363
Trop Anim Health Prod. 2008 Dec;40(8):607-13
pubmed: 18975125
Front Vet Sci. 2017 Feb 10;4:9
pubmed: 28239608
Vaccine. 2000 Aug 1;18(28):3272-9
pubmed: 10869772
PLoS Negl Trop Dis. 2015 Apr 16;9(4):e0003709
pubmed: 25881058
Bull World Health Organ. 1973 May;48(5):535-41
pubmed: 4544144
Nat Rev Microbiol. 2018 Apr;16(4):241-255
pubmed: 29479072
Vaccine. 2020 Sep 3;38(39):6162-6173
pubmed: 32616327
Lancet. 2014 Oct 11;384(9951):1389-99
pubmed: 24828901
Vaccine. 2003 May 16;21(17-18):1965-73
pubmed: 12706685
Trop Anim Health Prod. 2011 Jan;43(1):111-4
pubmed: 20676764
J Virol Methods. 2014 Aug;204:11-6
pubmed: 24731929
Proc Biol Sci. 2017 Dec 20;284(1869):
pubmed: 29263285
Clin Exp Vaccine Res. 2017 Jul;6(2):111-119
pubmed: 28775975
J Immunol Methods. 1998 Mar 1;212(1):79-87
pubmed: 9671155
Rev Sci Tech. 2018 Aug;37(2):691-702
pubmed: 30747116
BMC Vet Res. 2016 May 10;12:76
pubmed: 27164987
Lancet Infect Dis. 2002 Jun;2(6):327-43
pubmed: 12144896
Vet Med Int. 2011;2011:923149
pubmed: 21776359
BMC Vet Res. 2019 Dec 21;15(1):466
pubmed: 31864363
Philos Trans R Soc Lond B Biol Sci. 2013 Jun 24;368(1623):20120143
pubmed: 23798691
J Virol Methods. 2013 Feb;187(2):264-70
pubmed: 23201293
J Wildl Dis. 1988 Apr;24(2):246-58
pubmed: 3286905
Acta Vet Hung. 2011 Mar;59(1):149-54
pubmed: 21354950